BC060267 Inhibitors
BC060267, a protein of significant interest, plays a pivotal role in cellular processes, particularly those associated with cell cycle progression, survival, and fate determination. While its precise function is still under investigation, the identification of potential inhibitors sheds light on the intricate regulatory networks it engages in. Staurosporine, a broad-spectrum kinase inhibitor, offers a versatile approach to modulating BC060267 indirectly by targeting multiple kinases. This interference may disrupt cellular processes linked to cell cycle progression and survival, providing valuable insights into the regulatory mechanisms of BC060267. SB216763, a GSK-3 inhibitor, highlights the potential involvement of Wnt signaling in BC060267 modulation, influencing cellular processes associated with cell fate determination.
Inhibition of PI3K by LY294002 and Wortmannin underscores the significance of the PI3K pathway in BC060267 regulation, impacting cell survival and proliferation. MEK inhibitors PD98059 and U0126 shed light on the potential involvement of the MAPK pathway in BC060267 modulation, influencing cell growth and differentiation. Rapamycin, an mTOR inhibitor, and BAY 11-7082, an NF-κB inhibitor, provide additional insights into cellular processes associated with growth, proliferation, and immune responses. SB203580, a p38 MAPK inhibitor, and SP600125, a JNK inhibitor, suggest the influence of stress responses and specific signaling pathways on BC060267 modulation. The G9a inhibitor SP2509 indicates potential involvement of epigenetic regulation in BC060267 expression and function. AZD5363, an AKT inhibitor, further expands our understanding of BC060267 regulation by targeting AKT signaling associated with cell survival and proliferation. In conclusion, BC060267 inhibitors serve as powerful tools for unraveling its intricate role in cellular processes. The diverse pathways influenced by these inhibitors provide a foundation for future investigations, offering a comprehensive view of BC060267 and its potential implications in various biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor. Staurosporine targets multiple kinases, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with cell cycle progression and survival. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
GSK-3 inhibitor. SB216763 disrupts GSK-3 activity, potentially modulating BC060267 expression and function. This interference may impact cellular processes associated with Wnt signaling and cell fate determination. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor. LY294002 disrupts PI3K signaling, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with cell survival and proliferation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor. PD98059 targets MEK within the MAPK pathway, potentially modulating BC060267 expression and function. This interference may impact cellular processes associated with cell growth and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor. Rapamycin disrupts mTOR signaling, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with cell growth and proliferation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor. SB203580 influences the p38 MAPK pathway, potentially modulating BC060267 expression and function in specific cellular contexts. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor. Wortmannin disrupts PI3K signaling, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with cell survival and proliferation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. SP600125 disrupts the JNK signaling pathway, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with stress responses and cell survival. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB inhibitor. BAY 11-7082 disrupts NF-κB signaling, potentially influencing BC060267 indirectly. This interference may impact BC060267 expression and function, altering cellular processes associated with inflammation and immune responses. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
G9a inhibitor. SP2509 targets G9a histone methyltransferase, potentially influencing BC060267 expression and function. This interference may impact cellular processes associated with epigenetic regulation and gene expression. | ||||||